PATH
Menu

This fact sheet provides information about the use of the hormone oxytocin in the Uniject device to prevent postpartum hemorrhage. It summarizes the benefits of using this innovative solution and also provides a success story based on a pilot study conducted in Mali.

Corporate author(s): PATH, POPPHI

Publication date: December 2009

Available materials

English

Innovative Solutions Saving Mothers’ Lives

168 KB PDF

Hard copies are not available.

Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.

Region: Global

See also:

Health technologiesSafe injection

Maternal and child healthSafe birth and newborn care

For more information…

Contact: PATH Publications
Email: publications@path.org
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA